Comparison of Inosine-Monophosphate-Dehydrogenase Activity in Patients With Enteric-Coated Mycophenolate Sodium or Mycophenolate Mofetil After Renal Transplantation

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2524-2528

  Rath, T ^a   Kupper M ^b  

^a Westpfalz Klinikum GmbH   (Germany)

^b Institute of Immunology and Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; EVEROLIMUS; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; ENTERIC COATED TABLET; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TABLETS, ENTERIC-COATED; TACROLIMUS; YOUNG ADULT;

EID: 69149096137     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.124     Document Type: Article

References (15)

1. Johnston A., He X., and Holt D.W. Bioequivalence of enteric-coated mycophenolate sodium and mycophenolate mofetil: a meta-analysis of three studies in stable renal transplant recipients. Transplantation 82 (2006) 1413
2. Langman L.J., Shapiro A.M., Lakey J.R., et al. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model. Transplantation 61 (1996) 87
3. Langman L.J., LeGatt D.F., Halloran P.F., et al. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients. Transplantation 62 (1996) 666
4. Glander P., Hambach P., Braun K.P., et al. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients. Int J Clin Pharmacol Ther 41 (2003) 470
5. Budde K., Braun K.P., Glander P., et al. Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients. Transplant Proc 34 (2002) 1748
6. Glander P., Hambach P., Braun K.P., et al. Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation. Am J Transplant 4 (2004) 2045
7. Glander P., Braun K.P., Hambach P., et al. Non-radioactive determination of inosine 5′-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells. Clin Biochem 34 (2001) 543
8. Zucker K., Rosen A., Tsaroucha A., et al. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transpl Immunol 5 (1997) 225
9. van Hest R.M., Mathot R.A., Pescovitz M.D., et al. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. J Am Soc Nephrol 17 (2006) 871
10. Cattaneo D., Cortinovis M., Baldelli S., et al. Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients. Clin J Am Soc Nephrol 2 (2007) 1147
11. Budde K., Bauer S., Hambach P., et al. Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients. Am J Transplant 7 (2007) 888
12. Sanchez F.A., Calvo N., Moreno M.A., et al. Better mycophenolic acid 12-hour trough level after enteric-coated mycophenolate sodium in patients with gastrointestinal intolerance to mycophenolate mofetil. Transplant Proc 39 (2007) 2194
13. Devyatko E., Dunkler D., Bohdjalian A., et al. Lymphocyte activation and correlation with IMPDH activity under therapy with mycophenolate mofetil. Clin Chim Acta 394 (2008) 67
14. Sanquer S., Breil M., Baron C., et al. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil. Clin Pharmacol Ther 65 (1999) 640
15. Vethe N.T., Mandla R., Line P.D., et al. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment. Scand J Clin Lab Invest 66 (2006) 31